Investing for life: Meeting poor people's needs for access to medicines through responsible business practices

There are major shortcomings in the pharmaceutical industry's current
initiatives to ensure that poor people have access to medicines. To
shore up its own flagging economic performance, the industry is
increasingly looking to the potentially huge markets within emerging
economies. Yet, poor people who live in these countries still
desperately lack affordable and appropriate medicines. The time is ripe
for a bold new approach. The industry must put access to medicines at
the heart of its decision-making and practices. This is both a more
sustainable long-term business strategy and would allow the industry to
better play its role in achieving the universal right to health.

investing-for-life-meeting-poor-people2019s-needs-for-access-to-medicines-through-responsible-business-practices.pdf